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Aim:  To  summarise  the  evidence  from  randomised  controlled  trials  of mechanical  chest  compression
devices  used  during  resuscitation  after  out  of  hospital  cardiac  arrest.
Methods:  Systematic  review  of studies  evaluating  the  effectiveness  of mechanical  chest  compression.
We  included  randomised  controlled  trials  or cluster  randomised  trials  that  compared  mechanical  chest
compression  (using  any  device)  with  manual  chest  compression  for adult  patients  following  out-of-
hospital  cardiac  arrest.  Outcome  measures  were  return  of spontaneous  circulation,  survival  of event,
overall  survival,  survival  with  good  neurological  outcome.  Results  were  combined  using  random-effects
meta-analysis.
Data  sources:  Studies  were  identiﬁed  by  searches  of  electronic  databases,  reference  lists  of other  studies
and  review  articles.
Results: Five  trials were  included,  of  which  three  evaluated  the  LUCAS  or LUCAS-2  device  and  two  eval-
uated  the  AutoPulse  device.  The  results  did  not  show  an  advantage  to the use of mechanical  chest
compression  devices  for  survival  to  discharge/30  days  (average  OR  0.89, 95%  CI 0.77,  1.02)  and  survival
with  good  neurological  outcome  (average  OR 0.76,  95%  CI  0.53,  1.11).
Conclusions:  Existing  studies  do not  suggest  that mechanical  chest  compression  devices  are  superior  to
manual  chest  compression,  when  used  during  resuscitation  after  out  of  hospital  cardiac  arrest.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Out of hospital cardiac arrest is a major cause of death and
orbidity.1 Survival rates are low; in the UK, only around 7% of
atients in whom resuscitation is attempted, survive to discharge
rom hospital.2 A key factor that improves survival is good quality
ardiopulmonary resuscitation (CPR).3,4The quality of CPR delivered at out-of-hospital cardiac arrest is
ften sub-optimal.5 Fatigue and the need to deliver multiple tasks
n arrival at a cardiac arrest likely limit the quality of CPR that
 A Spanish translated version of the abstract of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2015.07.002.
∗ Corresponding author.
E-mail address: s.gates@warwick.ac.uk (S. Gates).
ttp://dx.doi.org/10.1016/j.resuscitation.2015.07.002
300-9572/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
paramedics can provide. Mechanical chest compression devices
provide compressions of standard depth and frequency for pro-
longed periods without any decline in quality and remove the need
for paramedics to provide chest compressions manually, enabling
them to concentrate on other aspects of patient care.6
Several different types of mechanical chest compression device
have been proposed, but the main technologies are piston devices
and load-distributing bands. Piston devices such as LUCAS-2 (Jolife
AB, Sweden) use a piston mounted on a frame that ﬁts around the
patient’s chest. The piston is driven up and down by a power source
such as compressed air or an electric motor, compressing the chest
in a similar way  to manual chest compressions. Load-distributing
band devices, such as AutoPulse (Zoll Medical Corporation, Chelms-
ford, MA), work in a different way. They consist of a wide band that
ﬁts around the chest, whose circumference is alternately shortened
and lengthened, providing rhythmic chest compressions.
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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search   
(n = 345) 
Full-text arcles assessed 
for eligibility 
(n = 7) 
Records  exc lude d 
(duplicat e or not  re levant) 
(n = 338) 
Full-text arcles excluded  
(n = 2) 
In-hospital study n=1 
Quasi-randomised n=1 
Included in  revi ew 
(n = 5) 2 S. Gates et al. / Resu
Three large randomised controlled trials that compared
echanical with manual chest compression, and evaluated their
ffects on clinically important outcomes, have recently been
eported, but not yet included in systematic reviews. The aim
f this paper is to combine, where appropriate, the results from
andomised trials, to estimate the effects on important outcomes
especially survival and survival with good neurological outcome)
f mechanical chest compression devices used to provide chest
ompressions for adult patients after out of hospital cardiac arrest.
. Methods
Studies were eligible for inclusion if they were individually ran-
omised or cluster randomised trials that compared the use of a
echanical chest compression device with standard manual chest
ompression in adult patients following out of hospital cardiac
rrest. There was no restriction of eligibility based on language
f publication. Quasi-randomised trials, for example, those ran-
omised by birth date or days of the week, were excluded. Studies
ere not included in analyses if they reported insufﬁcient informa-
ion to allow assessment of their risk of bias. Screening, decisions
bout inclusion and data extraction were performed by one author
nd checked by a second author. The review protocol was not pre-
egistered or published.
We  searched electronic resources (Medline, EMBASE and the
ochrane Central register from 1990 to February 2015) and the
eference lists of studies and review articles (last search February
015). We  based our search strategies on that published by the
ochrane review of mechanical chest compression devices,7 which
sed a combination of search terms to describe the condition (car-
iac arrest), the intervention (mechanical compression devices)
nd the study design (randomised controlled trials).
For each eligible study, we extracted information about the
tudy’s population and methodology, and the following outcomes;
eturn of spontaneous circulation (ROSC); survived event (sus-
ained ROSC until handover to a hospital emergency department);
urvival to hospital discharge or 30 days; and survival with good
eurological outcome. Good neurological outcome was deﬁned as
ither a Cerebral Performance Category (CPC) score of 1 or 2, or
odiﬁed Rankin Scale (mRS) score of between 0 and 3.8 Where
tudies presented a treatment effect estimate adjusted for impor-
ant covariates (e.g. clustering, initial rhythm, bystander CPR, EMS
esponse time, age) we used this estimate in meta-analyses in pref-
rence to unadjusted results.
We  used the Cochrane Risk of Bias tool to assess studies’ risk
f bias. This assesses seven domains; generation of random allo-
ation sequence, allocation concealment, blinding of participants
nd study personnel, blinding of outcome assessment, incomplete
utcome data, selective reporting, and other sources of bias. For
ach study, we assessed the methods used to address each poten-
ial source of bias, and summarised them in tabular form. We  did
ot produce an overall bias risk judgement or score, but assessed
ach domain separately.
We  combined studies using the Review Manager (RevMan) soft-
are version 5.3. Because there may  be differences in treatment
ffect between trials, especially those using different devices, we
sed a random-effects model. We  used the generic inverse variance
ethod in RevMan to estimate the average treatment effect (odds
atio) for each outcome, and the uncertainty around it, measured
y the 95% conﬁdence interval. We  also calculated 95% prediction
ntervals,9 to estimate the range of plausible treatment effects.
e quantiﬁed heterogeneity in each analysis by the tau-squared
nd I-squared statistics. Studies were subgrouped by the type of
echanical compression device used, as different devices oper-
te in different ways and hence could have different treatmentFig. 1. Flow chart of studies.
effects. Our primary analysis compared mechanical compression
with manual compression, and we performed a subgroup analysis
by type of device, to explore whether there was any evidence that
treatment effects differed between devices.
Some of the included trials presented several results using
different adjustments for covariates and design elements. We
performed sensitivity analyses to explore the effects of using dif-
ferently adjusted results for these trials. In addition, PARAMEDIC
presented CACE (complier average causal effect) estimates, to esti-
mate the treatment effect in the presence of non-compliance.10,11
We  performed additional sensitivity analyses to explore the effects
of using these estimates.
3. Results
The search located ﬁve eligible studies12–16 (Fig. 1). Two  tri-
als evaluated the AutoPulse device, and three evaluated the LUCAS
device. Two of the studies used a cluster randomised design, one
(PARAMEDIC) randomising by ambulance service vehicles, and the
other (ASPIRE) using ambulance stations or groups of stations as
the clusters; this study also incorporated crossovers at prespeci-
ﬁed points between the intervention and control groups. The other
three studies employed individual randomisation, using sealed
envelopes or cards carried with the device, which were accessed
by the paramedic at the time of the resuscitation attempt. Study
characteristics and risk of bias are summaried in Table 1.
There were a number of differences between the studies in addi-
tion to the chest compression device used, which may  have caused
differences in treatment effects and hence introduce heterogene-
ity into the meta-analyses. In two studies the LUCAS device was
used as part of a modiﬁed treatment algorithm,13,14 whereas in the
third LUCAS study mechanical chest compression was  simply used
to replace manual compression in the standard algorithm.16 One
of the trials of AutoPulse conducted extensive training to optimise
the quality of manual CPR that was  provided to the control group17;
in contrast other trials did not provide extra training but the con-
trol group received CPR as it would be provided in standard clinical
practice.
The randomisation methods of the studies appeared to be ade-
quate, although four studies did not provide any information on
the generation of the random allocation sequence. One concern
with individual randomisation was that it would be possible for
ambulance staff to open randomisation envelopes early and subvert
the randomisation scheme. No studies reported any problems with
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Table 1
Characteristics of studies and bias risk assessments.
Study Unit of
randomisation
Study
setting
Recruitment
period
Intervention Number of
participants
Sequence
generation
Allocation
concealment
Blinding;
patients and
clinicians
Blinding:
outcome
assessment
Percentage of participants
with missing data for each
outcome
Selective
reporting
Other sources of
bias
ASPIRE 2006 Cluster – crossover
at predetermined
intervals
USA/Canada 2004–2005 AutoPulse 767
51 clusters
(EMS stations
or groups of
stations)
No information Not concealed;
ambulance staff
aware of
intervention
Not blinded Unclear Survival: 0%
Survival with CPC 1–2:
0.7%
Primary analysis included
767 “primary” cases. 304
“nonprimary” cases and
306 with exclusion
criteria excluded
No evidence Participants with
missing CPC were
8.3% of survivors
Smekal 2011 Patient Sweden 2005–2007 LUCAS 148 No information Sealed
randomisation
letter carried with
device, opened at
time of
randomisation
Not blinded Unclear Survival: 0.7%
ROSC: 1.4%
Survived event: 0.7%
No evidence
LINC 2014 Patient Sweden, UK,
Netherlands
2008–2012 LUCAS/LUCAS-2 2589 No information Sealed opaque
envelopes carried
in ambulance,
opened at time of
randomisation
Not  blinded Unclear Survival: 1.1%
ROSC: 0.1%
Survived event: 0%
Survival with CPC 1–2:
1.1%
No evidence
CIRC 2014 Patient Austria,
Netherlands,
USA
2009–2011 AutoPulse 4231 No information Sealed
randomisation
cards opened when
indication for CPR
was found
Not blinded “Not always
blinded”
Survival: 0.3%
ROSC: 0%
Survival with mRS 0–3:
2.8%
522 participants satisfying
exclusion criteria
excluded
post-randomisation.
Primary analysis excluded
participants in “run-in”
phase and those recruited
in early part of trial when
battery issues led to poor
compliance.
No evidence Participants with
missing mRS were
27.7% of survivors
PARAMEDIC
2015
Cluster UK 2010–2013 LUCAS-2 4471
418 clusters
(vehicles)
Computer-
generated stratiﬁed
by station and
vehicle type
Not concealed;
ambulance staff
aware of
intervention
Not blinded Survival from
routine data.
Neurological
status
assessment
blinded
Survival: 0%
ROSC: 3.1%
Survived event: 4.7%
Survival with CPC 1–2:
0.2%
No evidence Participants with
missing CPC were
2.5% of survivors
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ndividual randomisation procedures, such as missing randomisa-
ion cards that could not be accounted for (which might indicate
hat crews had selected the intervention), or large numbers of eli-
ible patients that were not recruited (which might suggest that
he crew felt that the randomised allocation would not be good for
he patient).
Blinding of clinicians providing care was clearly not possible,
nd participants who survived may  also have been aware of which
llocation they had received. For example, use of the LUCAS device
ay  leave characteristic marks on the patient’s chest. Assessment
f survival outcomes was unlikely to have been affected by whether
r not the people assessing the outcome were blinded. One study
tated that personnel assessing neurological status (CPC or mRS)
ere blinded; in other studies this was unclear. It is conceivable
hat knowledge of treatment allocations could inﬂuence assess-
ents of neurological status; if assessors had strong views on
he effectiveness of the intervention being tested, they may  have
djusted their threshold for allocating a patient to an mRS  or CPC
ategory. We  cannot exclude this potential bias in studies where
utcome assessment was not blinded.
In all trials, the proportion of missing outcome data was  low,
hen measured as a percentage of all study participants. However,
n some trials, there was potentially bias due to missing data in the
ssessment of neurologically intact survival. This was because the
issing data were concentrated among survivors; for example, in
IRC, although only 2.8% of participants had missing mRS  data, they
epresented 27.7% of survivors. The populations included varied
etween trials. In ASPIRE, results were presented for a prespeci-
ed “primary” population (patients who were in cardiac arrest at
he time of EMS  arrival and whose cardiac arrest was  considered to
e of cardiac origin). Patients who fulﬁlled exclusion criteria were
reated according to trial allocation but subsequently excluded (in
rder not to introduce delays to treatment), but 304 “nonprimary”
ases were also excluded from the main results. In CIRC, there were
lso 522 post-randomisation exclusions of patients fulﬁlling exclu-
ion criteria. However, this trial also excluded patients recruited
n a prespeciﬁed run-in phase, an unspeciﬁed number of patients
ecruited early in the trial (after the run-in period) when compli-
nce with AutoPulse was found to be poor due to battery issues,
nd data from one site for a three-month period when that site
as non-compliant with the study protocol (number not stated).
The CIRC trial used a group-sequential design with predeﬁned
topping boundaries for superiority, inferiority and equivalenceneous circulation.
(double triangular test).17,18 The trial report presented treatment
effect estimates adjusted for clinical covariates for all outcomes,
but additionally adjusted the primary outcome (survival to hospital
discharge) for the sequence of interim analyses. In this review we
have used the results adjusted for covariates but not for the interim
analyses, because these are consistent and based on the data rather
than the decision making process. We  explored the effect of the
adjustment of the primary outcome for interim analyses with a
sensitivity analysis.
The meta-analyses (Figs. 2–5) do not suggest an advantage to
mechanical chest compression, using either device, for any of the
outcomes. Conﬁdence intervals and prediction intervals were wide,
reﬂecting the low incidence of favourable outcomes after out-of-
hospital cardiac arrest, and consequent imprecision of treatment
effect estimates.
For ROSC (Fig. 2), although there was no evidence of an over-
all difference between mechanical and manual chest compression
(average OR 0.96, 95% CI 0.85, 1.10, 95% prediction interval 0.66,
1.41), there was  some evidence that the effects of LUCAS and
AutoPulse were different (I2 for subgroup differences 78.5%). There
was data from only one AutoPulse trial, but that suggested a lower
proportion achieving ROSC in the mechanical chest compression
group.
Survival of event was only reported by trials that used LUCAS
(Fig. 3); the results were consistent across trials and suggested no
advantage to mechanical chest compression devices (OR 0.95, 95%
CI 0.85, 1.07, 95% prediction interval 0.45, 2.00).
The analysis of survival to discharge or 30 days (Fig. 4), again
suggested no advantage to mechanical chest compression (OR 0.89,
95% CI 0.77, 1.02, 95% prediction interval 0.71, 1.12). The point esti-
mate was  in the direction of favouring manual chest compression,
and the upper 95% conﬁdence limit was only just greater than 1.
There was  no evidence of heterogeneity of treatment effects. Sen-
sitivity analysis using the estimate for CIRC adjusted for interim
analyses as well as covariates did not make a major difference to
the overall average treatment effect (OR 0.94, 95% CI 0.79, 1.11, 95%
prediction interval 0.62, 1.43). Similarly, sensitivity analyses using
the CACE estimates for PARAMEDIC did not make a substantial
difference to the overall result.Results for survival with good neurological outcome (Fig. 5)
were more heterogeneous than for other outcomes (I2 68%). This
was not due to differences between LUCAS and AutoPulse, which
were small (I2 for subgroup differences 11%), but to inconsistency
S. Gates et al. / Resuscitation 94 (2015) 91–97 95
Fig. 3. Survived event (i.e. sustained ROSC to handover to hospital emergency department).
Fig. 4. Survival to discharge from hospital or 30 days.
Fig. 5. Survival with CPC 1–2 or mRS  0–3.
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such situations. The use of mechanical devices for in-hospital car-6 S. Gates et al. / Resu
etween the results of the two trials of each device. Reasons for the
nconsistency were unclear. Overall, there was no evidence that the
verage treatment effect favoured mechanical chest compression,
ut the 95% prediction interval was very wide (OR 0.76, 95% CI 0.53,
.11, 95% prediction interval 0.17, 3.49).
. Discussion
Five randomised trials, involving over 10,000 participants, were
ncluded. The meta-analyses found no evidence of beneﬁt with the
se of mechanical chest compression devices. Results for survival
ith good neurological outcome were heterogeneous, and both
onﬁdence intervals and prediction intervals were wide, and do
ot rule out beneﬁt in some trials. Because of the inclusion of recent
arge trials in this review, our conclusions can be ﬁrmer than those
f the most recent update of the Cochrane review.7 They also dif-
er from those of another recent review and meta-analysis,19 which
ound, mainly from observational evidence, an improvement in the
dds of ROSC with mechanical chest compression.
The trials recruited unselected populations of patients typical
f clinical practice in the geographical areas in which they were
onducted. Despite the large size of many of the trials included in
he review, conﬁdence intervals around the combined treatment
ffect estimates were relatively wide, because of the low survival
ate from out of hospital cardiac arrest. The methodological qual-
ty of the included studies was generally good. Secure methods of
andomisation were used, and for most outcomes there were few
issing data. Trials using a cluster randomised design were unable
o conceal allocations in advance of assignment, and ambulance
rews would have been aware of the allocation. This could have led
o inclusion bias, in two ways. First, patients might not be reported
o the trial if it was felt that they were not receiving the best allo-
ation. PARAMEDIC guarded against this by including all eligible
ardiac arrests that were attended by trial vehicles. It was not clear
hether this was also the case in ASPIRE. Second, the threshold for
nitiating a resuscitation attempt could have varied according to the
ntervention. For example, if a crew believed strongly that mechani-
al chest compression was better, they might initiate a resuscitation
ttempt in a situation where they would not if manual chest com-
ression was to be used. In PARAMEDIC, the Data Monitoring
ommittee reviewed evidence for differential thresholds for resus-
itation, but did not ﬁnd evidence of any appreciable selection bias.
The ASPIRE trial found unfavourable results for survival and neu-
ological outcome, and it was suggested that these effects were
argely due to heterogeneity of treatment effects between sites. A
e-analysis20 of the trial, by researchers associated with the device
anufacturers, found that the unfavourable outcomes may  have
een due to one trial site (of ﬁve), where the protocol was changed
art-way through the study, resulting in a delay in the start of
echanical chest, which could have led to worse outcomes. How-
ver, the study investigators disagreed with this interpretation.21
The use of the double triangular test design in the CIRC trial
aises a number of issues. The adjustment of the ﬁnal analysis to
llow for the interim analyses had a large effect on the primary
utcome (survival to hospital discharge), changing the point esti-
ate of the odds ratio from 0.89 to 1.06. The secondary analyses
ere not adjusted for the interim analyses, so the results for the
rimary and secondary outcomes were not directly comparable.
dditionally, the boundaries for equivalence in the double trian-
ular test were very generous; if the “equivalence” boundary were
rossed, the 95% conﬁdence interval would be contained between
og-odds of −0.37 and 0.37 (i.e. odds ratio of 0.69 and 1.45).15 This
nterval includes values that would represent substantial beneﬁt
nd substantial harm, so the conclusion of “equivalence” in this
ituation is questionable.n 94 (2015) 91–97
In some trials, a high proportion of survivors had missing data for
neurologically intact survival. This was most severe in CIRC, where
27.7% of survivors lacked data for this outcome. This reﬂects the
difﬁculty of performing follow-up assessments on cardiac arrest
survivors, but clearly has the potential to introduce bias. It is pos-
sible, or even likely, that there could be an association between
missingness and neurological outcome. There are many plausible
reasons why patients with poor outcomes may  be more likely to be
lost, for example, they may  be harder to contact because they have
moved to a residential care facility, or they may  be less willing or
able to undertake follow-up assessments.
Non-compliance was a major issue in PARAMEDIC, where 40%
of the mechanical chest compression group actually received this
intervention. It was designed as a pragmatic trial, so some non-
compliance, which would occur in normal clinical practice, was
anticipated. This would include cases where the patients was  too
large or too small for LUCAS, the LUCAS could not be deployed due
to space restrictions, or where the original call was not for cardiac
arrest, and the arrest occurred while the patient was being treated
by a solo responder. The PARAMEDIC investigators also carried out
CACE analyses to assess the treatment effects of LUCAS when it was
actually used. These analyses conﬁrmed the overall analyses: the
treatment effects were similar when LUCAS was  actually used, pro-
viding evidence that the non-compliance was  not causing failure to
ﬁnd a treatment beneﬁt.
Quality of CPR provided in the manual chest compression arms
of the trials could affect the results; if manual chest compression
was high quality, mechanical devices may  not appear superior, as
one of their main beneﬁts is to provide consistent chest compres-
sions over long periods, which is known to be difﬁcult for humans.
Measuring the quality of CPR in a large trial is very challenging,
but several of the trials did provide some information. In CIRC, CPR
quality data were collected from 96% of participants, and showed
compression fractions in the ﬁrst 5 min  of 79.0% (sd 12.3%) in the
manual group and 74.7% (sd 12.7%) in the mechanical arm. The tar-
get compression rates in the two  arms of this trial were different:
100/min in the manual arm and 80/min in the mechanical arm. The
target was  achieved more often in the manual arm: median com-
pression rate in the manual arm was  89.9 (IQR 79.3, 100.3), but in
the mechanical arm it was  65.9 (IQR 61.3, 70.2). In LINC compres-
sion fraction was  recorded from 10% of patients, and was 84% in
the mechanical compression group and 78% in the manual group.
ASPIRE recorded compression fraction in the ﬁrst 5 min  from 45%
of the manual compression group and 52% of the mechanical com-
pression group; it was  very similar, at 0.6 (sd 0.2) in the manual
arm and 0.59 (sd 0.21) in the mechanical arm. The remaining two
trials did not report any information on CPR quality.
5. Conclusion
Meta-analyses of the results from randomised controlled which
enrolled over 10,000 patients do not suggest that mechanical chest
compression devices are superior to manual chest compression,
when used routinely during resuscitation after out of hospital car-
diac arrest. The widespread deployment of devices based on clinical
effectiveness does not seem justiﬁed. Nevertheless, it is likely that
mechanical chest compression devices will continue to play a role
in resuscitation. Mechanical devices can deliver chest compressions
where manual CPR is difﬁcult or impossible, such as during ambu-
lance transport, and are likely to be the best treatment option indiac arrest has not been evaluated in randomised trials, but the
results for prehospital studies may  not extrapolate to this setting.
Mechanical devices may  also be used as a bridge to advanced treat-
ments such as extracorporeal membrane oxygenation.6
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